Topical Tacrolimus for Breast Cancer-related Lymphedema

NCT06306274 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ENROLLING_BY_INVITATION

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Lymphedema

Interventions

DRUG: Tacrolimus
DRUG: Placebo

Sponsor

Odense University Hospital